<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Regulatory Affairs on FinanClub</title>
    <link>https://finan.club/tags/regulatory-affairs/</link>
    <description>Recent content in Regulatory Affairs on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 18 Dec 2023 09:02:53 +0000</lastBuildDate><atom:link href="https://finan.club/tags/regulatory-affairs/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>OGN</title>
      <link>https://finan.club/us/ogn/</link>
      <pubDate>Mon, 18 Dec 2023 09:02:53 +0000</pubDate>
      
      <guid>https://finan.club/us/ogn/</guid>
      <description>score:124
Chances: Organon has shown a strong commitment to providing innovative health solutions within women&amp;rsquo;s health, biosimilars, and established brands.The partnership with Sempre Health to improve prescription adherence shows a forward-thinking approach to patient care.Participation in the Piper Sandler Healthcare Conference demonstrates a proactive approach to investor engagement.</description>
    </item>
    
  </channel>
</rss>
